Debra C Quenelle

Author PubWeight™ 13.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections. Antimicrob Agents Chemother 2004 1.79
2 Oral treatment of murine cytomegalovirus infections with ether lipid esters of cidofovir. Antimicrob Agents Chemother 2004 1.42
3 Activity and mechanism of action of N-methanocarbathymidine against herpesvirus and orthopoxvirus infections. Antimicrob Agents Chemother 2006 1.37
4 Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs. Vaccine 2005 1.12
5 Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12. J Virol 2012 1.06
6 Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides. Antimicrob Agents Chemother 2009 0.95
7 Isolation and characterization of cidofovir resistant vaccinia viruses. Virol J 2008 0.92
8 CMX001 potentiates the efficacy of acyclovir in herpes simplex virus infections. Antimicrob Agents Chemother 2011 0.92
9 Human cytomegalovirus UL27 is not required for viral replication in human tissue implanted in SCID mice. Virol J 2006 0.85
10 Activities of certain 5-substituted 4'-thiopyrimidine nucleosides against orthopoxvirus infections. Antimicrob Agents Chemother 2008 0.84
11 Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides. J Med Virol 2003 0.81
12 Vaccinia virus lacking the deoxyuridine triphosphatase gene (F2L) replicates well in vitro and in vivo, but is hypersensitive to the antiviral drug (N)-methanocarbathymidine. Virol J 2008 0.79
13 Synthesis and antiviral activity of 6-deoxycyclopropavir, a new prodrug of cyclopropavir. Bioorg Med Chem 2012 0.75
14 Efficacy of rifabutin-loaded microspheres for treatment of Mycobacterium avium-infected macrophages and mice. Drug Deliv 2007 0.75